Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: Effect of inhibition of nitric oxide synthesis

Heart

Volumn 78, Issue 5, 1997, Pages 493-498

  Kato, Masaya ^a   Shiode, Nobuo ^a   Yamagata, Togo ^a   Matsuura, Hideo ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bradykinin; Coronary artery; Coronary blood flow; Nitric oxide

Indexed keywords

BRADYKININ; N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DILATATION; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DOPPLER FLOWMETRY; EPICARDIUM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL;

EID: 0030735155     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.5.493     Document Type: Article

References (37)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
2. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557-573
3. Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis 1988;30:349-80.
4. Luscher TF, Richard V, Tschudi M, Yang Z, Boulanger C. Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 1990;15:519-27.
5. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandins, endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 1979;30:293-331.
6. Shimokawa H, Flavahan NA, Lorenz RR, Vanhoutte PM. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in porcine coronary artery. Br J Pharmacol 1988;95:1197-203.
7. Nakashima M, Mombouli J-V, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 1993;92:2867-71.
8. Komori K, Lorenz RR, Vanhoutte PM. Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol 1988;255:H207-12.
9. Boulanger CM, Hendrickson H, Lorenz RR, Vanhoutte PM. Release of different relaxing factors by cultured porcine endothelial cells. Circ Res 1989;64:1070-8.
10. Nagao T, Vanhoutte PM. Hyperpolarization contributes to endothelium-dependent relaxations to acetylcholine in femoral veins of rats. Am J Physiol 1994;261:H1034-7.
11. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biochemical activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
12. Hutchinson PJA, Palmer RMJ, Moncada S. Comparative pharmacology of EDRF and nitric oxide on vascular strips. Eur J Pharmacol 1987;141:445-51.
13. Moncada S, Radomski MW, Palmer RMJ. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988;37:2495-501.
14. Cherry P, Furchgott RF, Zawadzki JV, Jothianandan D. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA 1982;79:2106-10.
15. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994; 90:35-41.
16. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995;91:1732-8.
17. Kuga T, Egashira K, Mohri M, Tsutsui H, Harasawa Y, Urabe Y, et al. Bradykinin-induced vasodilation is impaired at the atherosclerotic site hut is preserved at the spastic site of human coronary arteries in vivo. Circulation 1995;92:183-9.
18. Groves P, Kurz S, Just H, Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation 1995;92:3424-30.
19. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989;96:418-24.
20. Ofili K, Kern MJ, Tatineni S, Deligonul U, Aguirre F, Serota H, et al. Detection of coronary collateral flow by a Dopplcr-tipped guide wire during coronary angioplasty. Am Heart J 1991;122:221-5.
21. Doucette JW, Corl PD, Payne HM, Flynn AK, Goto M, Nassi M, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899-911.
22. Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, Kajiyama G. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. J Am Coll Cardiol 1996;27:304-10.
23. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-8.
24. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993;88:43-54.
25. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, et al. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest 1995;95:1747-55.
26. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995;92:320-6.
27. Lieberman EH, Knab ST, Creager MA. Nitric oxide mediates the vasodilator response to flow in humans [abstract]. Circulation 1994;90:I-138.
28. Mombouli J-V, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 1992;71:137-44.
29. Nagao T, Vanhoutte PM. Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J Physiol (Lond) 1992;445:355-67.
30. Kamiya A, Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol 1980;239:H14-21.
31. Zanzinger J, Zheng X, Bassenge E. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc Res 1994;28:209-14.
32. Pelc LR, Gross GJ, Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991;83:2048-56.
33. Dube S, Rajagopalan S, Canty JM. Nitric oxide independent relaxations to bradykinin are not inhibited by calmodulin antagonists in isolated porcine coronary resistance artenoles [abstract]. Circulation 1994;90:I-256.
34. Tschudi M, Richard V, Buhler FR, Luscher TF. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol 1991;260:H13-20.
35. Sudhir K, Chou TM, Hutchinson SJ, Chatterjce K. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric-oxide and bradykinin in conductance and resistance arteries. Circulation 1996;93:1734-9.
36. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, et al. Role of endothelium-derived nitric oxide in coronary vasodilation induced by pacing tachycardia in humans. Circ Res 1996;79:331-5.
37. Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia: comparison of acetylcholine and substance P. Circulation 1997;95:104-10.